1 1

Solar Shift

Peak Performance Powerhouse

Peak Performance Powerhouse

$275.00 AUD
$275.00 AUD
Sale Sold out
Taxes included.

Our Commitment to You: At Solar Shift, we care deeply about your wellness journey. The information provided is shared strictly for educational and research purposes. We are not medical professionals, and nothing shared here should be considered medical advice, treatment instructions, or prescriptions. Please always prioritize your health by doing your own research and consulting with a qualified healthcare professional regarding any health concerns. Research Purposes Only.

 

The combination of Retatrutide, MOTS-c, and Tesamorelin is considered an advanced, experimental metabolic "powerhouse stack" because it simultaneously attacks fat loss, insulin resistance, and muscle wasting from three entirely different biological directions. 

In alternative medicine and biohacking, it is used for aggressive body recomposition. It maximizes fat burning while protecting skeletal muscle during severe caloric deficits.

  • Retatrutide (The "Triple Agonist"): This represents the newest frontier in weight-loss peptides, targeting GLP-1, GIP, and Glucagon receptors. While GLP-1 and GIP suppress appetite, delay gastric emptying, and enhance insulin secretion, the addition of the glucagon receptor specifically spikes energy expenditure and directly triggers lipolysis (fat breakdown) in liver and adipose tissues.
  • MOTS-c (The Mitochondrial Regulator): This is a 16-amino-acid peptide encoded within mitochondrial DNA. Instead of directly altering appetite, it operates as a cellular exercise mimetic. It activates the AMPK pathway, which forces skeletal muscle to uptake glucose, boosts cellular metabolic flexibility, and enhances mitochondrial ATP production.
  • Tesamorelin (The Growth Hormone Secretagogue): This is a synthetic analogue of Growth Hormone-Releasing Hormone (GHRH). It signals the pituitary gland to release endogenous growth hormone. Its primary trait is its specific, clinically verified ability to reduce visceral adipose tissue (deep belly fat) while promoting nitrogen retention and protein synthesis to protect muscle.

How They Work Together 

 Solving Muscle Wasting

Rapid weight loss via intensive GLP-1 style drugs often causes significant muscle loss (cachexia) alongside fat loss. In this stack, Tesamorelin and MOTS-c act as a protective shield for lean mass. Tesamorelin increases Growth Hormone and IGF-1 to drive muscle synthesis, while MOTS-c signals the muscles to continuously utilize energy efficiently, even during a steep caloric deficit.

Dual-Action Fat Target (Subcutaneous + Visceral)

Retatrutide drives overall systemic fat loss by shifting the body into a caloric deficit and increasing baseline metabolic rate via glucagon. Tesamorelin specifically forces the body to burn stubborn visceral fat—the dangerous fat surrounding internal organs that is often highly resistant to diet and traditional GLP-1 therapies alone.

Overcoming Insulin Resistance and Plateaus

Chronic insulin resistance locks the body out of utilizing stored fat for fuel, causing weight loss plateaus. Retatrutide repairs this from the pancreatic and hormonal level, while MOTS-c repairs it from the cellular level by bypassing damaged insulin signaling and forcing muscles to burn glucose via AMPK activation. This restores "metabolic flexibility".


  • Research Status: It is currently a research-only, non-FDA-approved compound used in pre-clinical studies
  • DISCLAIMER ADDITIONAL INFORMATION
  • By completing this purchase, the buyer acknowledges that this material is intended strictly for laboratory research use. The purchaser represents and warrants that they are qualified to handle research chemicals and will use this product in compliance with all applicable laws, regulations, and safety guidelines. The buyer assumes full responsibility for the proper handling, storage, and use of this material. No representations or warranties are made regarding safety or efficacy for any purpose outside of controlled research settings..

 

 

View full details